Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Neurology indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Behavioural symptoms and capacity in dementia

Neurology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Time-critical presentation

Sudden agitation, drowsiness, hallucinations or refusal of care needs urgent assessment for delirium, pain, infection, retention, constipation, medicine toxicity, hypoxia and metabolic illness. Immediate serious harm may require proportionate emergency action, but dementia alone never authorises restraint, covert medication or treatment without a capacity and legal framework.

Overview

Formulate distress and behaviour in dementia through unmet need and delirium assessment, use antipsychotics only within strict risk criteria, and apply decision-specific Mental Capacity Act practice.

Behaviour is communication embedded in context. Agitation, shouting, wandering, resistance, apathy, sleep reversal, hallucinations or sexual disinhibition can arise from dementia pathology, but an abrupt change is delirium until assessed. Ask staff or carers for an antecedent-behaviour-consequence account and look for pain during movement or care, constipation, retention, dehydration, infection, breathlessness, hunger, unfamiliar carers, hearing or visual impairment, boredom, crowding, fear and cultural misunderstanding. Review anticholinergics, opioids, sedatives and recent withdrawal. A personalised formulation may reveal that apparent aggression occurs only during painful washing or that repeated walking expresses a former routine. Address the cause and modify the interaction before suppressing the response.

NICE restricts antipsychotics to risk of harm or severe distress from agitation, hallucinations or delusions after benefits and harms are discussed. Risks include stroke, increased mortality, sedation, falls, aspiration, extrapyramidal effects and metabolic disturbance.

Aetiology

01

Delirium and physical discomfort

Infection, pain, constipation, urinary retention, dehydration, breathlessness and medicine toxicity commonly cause abrupt behavioural change in dementia and should be sought before attributing it to progression.

02

Unmet need and environment

Hunger, sensory loss, unfamiliar carers, crowding, poor lighting, disrupted routine, boredom or frightening communication can generate distress that is expressed through agitation, withdrawal or resistance.

03

Neuropsychiatric manifestations

Degeneration of frontal, limbic and perceptual networks can produce apathy, disinhibition, hallucinations, delusions, sleep reversal and impaired emotional regulation.

04

Medicine and care effects

Anticholinergics, sedatives, opioids, dopamine-active medicines and abrupt withdrawal may worsen behaviour, while restraint or inconsistent responses can amplify fear and agitation.

Pathophysiology

  1. 1
    Reduced interpretation and control

    Dementia impairs memory, language, perception and executive regulation, limiting the person's ability to understand surroundings, express need or adapt to change.

  2. 2
    Stress response activation

    Pain, physiological illness or confusing care activates threat and arousal systems without adequate cognitive context, producing agitation, wandering, withdrawal or defensive behaviour.

  3. 3
    Behavioural reinforcement

    Environmental responses such as confrontation, repeated restraint or inconsistent routines may increase distress, while calm personalised communication and correction of triggers can reduce it.

Clinical features and red flags

Delirium superimposed on dementiaRed flag

Acute fluctuating attention, altered arousal, sleep-wake reversal or new perceptual symptoms over hours to days indicates urgent delirium assessment even with established dementia.

Unmet-need behaviour

Distress linked consistently to movement, personal care, noise, hunger, toileting or an unfamiliar approach suggests a modifiable physical or environmental antecedent.

Severe-distress threshold

Persistent frightening hallucinations or agitation causing profound distress may justify a cautious antipsychotic discussion after physical and environmental causes are addressed.

Lewy body sensitivityRed flag

Marked rigidity, reduced consciousness, autonomic instability or fever after an antipsychotic in Lewy body or Parkinson dementia is an emergency toxicity signal.

Decision-specific ability

A person may lack capacity for a complex property sale yet retain capacity to choose food or consent to a simple examination after information is adapted.

Undue influence or coercionRed flag

A superficially coherent decision made under pressure, fear or exploitation requires private assessment and safeguarding rather than assuming either capacity or incapacity resolves coercion.

Investigations

  1. 01
    Structured physical and delirium assessmentFirst step
    Why
    Find acute illness, pain and physiological causes behind new behavioural change.
    Interpretation and limitations
    Use observations, examination, 4AT or local tool and focused tests; a positive delirium screen changes treatment from chronic behaviour management to urgent cause correction.
  2. 02
    Antecedent-behaviour-consequence record
    Why
    Identify repeatable triggers, consequences and effective non-drug responses across times and carers.
    Interpretation and limitations
    Patterns guide environmental change and create an objective baseline; recording only labels such as aggressive provides little therapeutic information.
  3. 03
    Pain and sensory assessment
    Why
    Detect pain, hearing and visual impairment when verbal reporting is limited.
    Interpretation and limitations
    Use observation during movement, facial and vocal cues, collateral and examination; an analgesic trial should have a defined target and safety review.
  4. 04
    Decision-specific capacity assessment
    Why
    Establish whether an impairment causes inability to understand, retain, use or weigh, or communicate relevant information.
    Interpretation and limitations
    Document practicable support, relevant information, the person's own reasoning and the causal link; a diagnostic label or outcome disagreement is insufficient.

Differential diagnosis

01

Superimposed delirium

Hours-to-days onset, fluctuation and impaired attention favour delirium from acute illness or medicines rather than a simple step in chronic dementia progression.

02

Depression or primary psychosis

Persistent low mood, anhedonia or a coherent psychotic syndrome may require specific treatment, although late-onset symptoms still warrant cognitive and medical assessment.

03

Dementia with Lewy bodies

Well-formed visual hallucinations, marked fluctuation, REM sleep behaviour disorder and parkinsonism suggest Lewy-body disease, with important implications for antipsychotic sensitivity.

04

Akathisia or other drug effect

Inner restlessness with pacing after dopamine blockade supports akathisia; sedation, rigidity or dyskinesia likewise indicates treatment harm rather than worsening behavioural pathology.

Management

01Behaviour changeFind the need before choosing a drugFirst stepDistress, agitation, wandering, resistance or perceptual symptoms emerge or worsen.+
  1. 1Define onset and behaviour precisely, assess immediate harm and perform urgent delirium, pain, retention, constipation, infection and medicine review.
  2. 2Ask what happens immediately before and after episodes, including staff language, personal-care task, noise, lighting, hunger and sensory access.
  3. 3EscalationCo-design routine, meaningful activity, communication, comfort and environmental changes with family and care staff, documenting what de-escalates distress.
  4. 4EscalationMeasure response and reconsider diagnosis before psychotropic escalation, maintaining emergency safeguards when serious harm is imminent.
02Antipsychotic decision

Complications

01

Injury and safeguarding harm

Agitation, wandering, self-neglect or impaired judgement can lead to falls, exploitation, malnutrition, unsafe driving or harm during care.

02

Restraint and medicine toxicity

Physical restriction or sedating antipsychotics can cause aspiration, falls, stroke, extrapyramidal effects and loss of mobility, sometimes worsening the original behaviour.

03

Loss of supported decision-making

Failure to assess one decision at one time can lead to unjustified removal of autonomy, invalid consent or neglect of a lawful advance decision or representative.

04

Carer breakdown and institutionalisation

Persistent distress and night-time disruption can overwhelm family or care services, accelerating crisis admission or placement unless carers receive practical and emotional support.

Monitoring and follow-up

  • Record the target behaviour's frequency, severity, antecedents and consequences alongside pain, bowel, bladder, sleep and infection indicators.
  • For antipsychotics review alertness, mobility, swallowing, falls, orthostatic blood pressure, extrapyramidal signs, weight and relevant metabolic or ECG measures.
  • Reassess the indication early and at least every 6 weeks, documenting benefit, ongoing severe-distress or harm threshold and a reduction or stop plan.
  • Repeat capacity assessment when the decision, information, communication support or delirium changes; capacity findings do not transfer automatically across time or topics.
  • Review carer distress, safeguarding, restrictive practices and deprivation-of-liberty status so household or service strain does not silently determine treatment.

Special situations

Behaviour is data

The exact time, task and response can reveal pain or fear more reliably than a retrospective global label and can identify a practical intervention.

Memory is only one capacity component

The Act requires retention only long enough to decide; inability to recall the discussion tomorrow does not by itself prove incapacity today.

Unwise remains autonomous

Capacity law protects choices clinicians dislike, provided the person can make the specific decision without coercion and understands relevant consequences.

Family does not automatically consent

Relatives inform values and may hold formal authority, but next-of-kin status alone does not permit healthcare decisions for an adult lacking capacity.

A prescription needs an exit

Naming a target, review date and stopping criterion at initiation prevents antipsychotic use drifting from emergency symptom relief into indefinite chemical restraint.

Common pitfalls

  1. 01

    Calling abrupt agitation progression of dementia without assessing delirium, pain, urinary retention, constipation, hypoxia and medicine toxicity.

  2. 02

    Prescribing an antipsychotic because care is difficult rather than because documented severe distress or risk-of-harm criteria are met.

  3. 03

    Continuing psychotropic repeats without six-weekly reassessment, target measurement or an attempt to stop when benefit is absent.

  4. 04

    Using a dementia diagnosis or low cognitive score as a blanket finding that the person lacks capacity for every present and future decision.

  5. 05

    Treating disagreement as inability to use or weigh information instead of documenting the person's reasoning and causal effect of impairment.

  6. 06

    Accepting informal next-of-kin consent without checking capacity, lasting power of attorney, advance decisions and best-interests requirements.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
NeurologyOriginal SBA

First response to agitation

A care-home resident with dementia becomes suddenly agitated and strikes staff during morning washing. This behaviour is new. What is the best initial approach?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Neurology topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG97 dementia behaviour recommendationsStructured assessment, psychosocial care, antipsychotic thresholds and review.
  • Mental Capacity Act code of practiceStatutory principles, functional test, best interests and least restriction.
  • NICE CG103 delirium guidanceDetection and treatment of delirium superimposed on dementia.
  • MHRA antipsychotics in dementia safetyStroke, mortality and prescribing-reduction safety context.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Risperidone
has a narrow UK licence for short-term, up to 6 weeks, treatment of persistent aggression in moderate-to-severe Alzheimer disease unresponsive to non-drug approaches when there is risk of harm.
Haloperidol
's licence covers persistent aggression and psychotic symptoms in moderate-to-severe Alzheimer and vascular dementia in defined circumstances, but neurological and cardiac toxicity is substantial. Neither licence converts prescribing into an automatic choice. In Lewy body or Parkinson disease dementia, seek specialist input because sensitivity can be catastrophic. Continue psychosocial care during any drug trial and review at least every 6 weeks.

The Mental Capacity Act 2005 provides the framework in England and Wales. Begin by presuming capacity and take practicable steps: optimal time, familiar supporter, interpreter, hearing aids, simple chunks, visual material and treatment of delirium. Identify one actual decision and the information relevant to it. The diagnostic element is an impairment or disturbance of mind or brain; the functional element is inability because of that impairment to understand, retain long enough, use or weigh, or communicate. Retaining information briefly can be enough. An unwise decision does not equal incapacity. If capacity is absent, check valid advance decisions and health-and-welfare lasting power of attorney, involve the person, consider past and present wishes, beliefs and relevant others, and select the least restrictive best-interests option. Serious disputes, deprivation of liberty and treatment contrary to a valid refusal require senior legal processes, not informal family consent.

Key points

  • Describe the behaviour precisely—who, when, where, trigger, duration and consequence—rather than using 'challenging behaviour' as a diagnosis.
  • Before treatment perform a structured assessment for pain, delirium, infection, hunger, thirst, constipation, urinary retention, sleep, sensory loss, environment and communication.
  • Offer psychosocial and environmental interventions first when there is no emergency, matching meaningful activity, routine, lighting, noise and carer approach to the person.
  • Antipsychotics are considered only when the person is at risk of harming themselves or others, or has agitation, hallucinations or delusions causing severe distress.
  • Use the lowest effective antipsychotic dose for the shortest possible time, reassess at least every 6 weeks and stop if there is no clear ongoing benefit.
  • People with dementia with Lewy bodies or Parkinson disease dementia can have severe antipsychotic sensitivity with rigidity, sedation, autonomic collapse or neuroleptic malignant syndrome.
  • Capacity is presumed and is specific to the decision and time; a dementia diagnosis, eccentric choice or poor memory score does not establish incapacity globally.
  • A person lacks capacity only when an impairment of mind or brain means they cannot understand, retain, use or weigh relevant information, or communicate the decision despite practicable support.
  • Best-interests decisions consider the person's wishes, values and relevant others, exclude convenience or age-based assumptions and choose the least restrictive effective option.
05
Medicine and antipsychotic risk review
Why
Identify drugs worsening cognition and quantify vascular, cardiac, neurological, metabolic and fall risks before psychotropic use.
Interpretation and limitations
Deprescribe contributors where safe; Lewy body features, QT risk, stroke history or severe frailty may make antipsychotic harm especially high.
Use a narrow time-limited indication
Risk of harm or severe distress persists despite treatment of causes and personalised non-drug care.
+
  1. 1Document the qualifying target, baseline frequency, dementia subtype, Lewy body features and discussion of stroke, mortality, sedation, falls and movement harms.
  2. 2Select the least harmful option at the lowest effective dose under current BNF, licence and local specialist guidance, avoiding convenience sedation.
  3. 3Continue psychosocial measures and review effect and toxicity early and at least every 6 weeks, with family or advocate input where appropriate.
  4. 4Stop when no clear benefit remains, tapering if needed, and reopen the physical and environmental formulation if behaviour recurs.
03CapacitySupport, test and act lawfullyConsent, residence, finance, medication or another specific decision is disputed or consequential.+
  1. 1Name the exact decision and optimise time, communication, sensory aids, interpreter, treatment of delirium and access to a trusted supporter.
  2. 2Explain relevant information and assess understanding, retention, use or weighing and communication, linking any failure causally to impairment of mind or brain.
  3. 3If capacity is present, respect the decision even if others consider it unwise; address coercion and safeguarding as separate issues.
  4. 4If capacity is absent, check advance authority, involve the person and relevant consultees, record best-interests reasoning and implement the least restrictive lawful option.
Key medicines and prescribing safety2 treatments · regimens, roles and cautions+
May reduce severe persistent aggression in moderate-to-severe Alzheimer disease when non-drug approaches fail and there is risk of harm.

Risperidone

If strictly indicated, use a low geriatric starting dose and titrate cautiously; the licensed persistent-aggression course in Alzheimer disease is limited to 6 weeks.

Increased stroke and mortality risk, sedation, falls, orthostasis and extrapyramidal effects require consent and frequent review; avoid reflex use in Lewy body dementia.

A restricted option for persistent aggression or psychotic symptoms in defined Alzheimer or vascular dementia circumstances when non-drug treatment fails.

Haloperidol

Use only the lowest effective short-term dose within its narrow licence and local specialist protocol after ECG and interaction risks are considered.

QT prolongation, torsades, rigidity, dysphagia, aspiration and neuroleptic malignant syndrome are important; severe sensitivity can occur in Lewy body and Parkinson disease dementia.